Patents

StromaGenesis owns a diversified portfolio of 30 issued patents (28 Granted & 2 Nationalized) and 4 Patent Pending; covering therapeutic and diagnostic applications, providing broad international protection across multiple disease areas.

The Company’s patents protect the ownership of the following assets: